Literature DB >> 10799000

Gene therapy. The best of times, the worst of times.

W F Anderson1.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 10799000     DOI: 10.1126/science.288.5466.627

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  11 in total

Review 1.  Gene therapy in clinical medicine.

Authors:  S M Selkirk
Journal:  Postgrad Med J       Date:  2004-10       Impact factor: 2.401

Review 2.  Translating gene transfer: a stalled effort.

Authors:  Alexandra J Greenberg; Jennifer McCormick; Carmen J Tapia; Anthony J Windebank
Journal:  Clin Transl Sci       Date:  2011-08       Impact factor: 4.689

3.  Gene therapy: ethical issues.

Authors:  Isaac Rabino
Journal:  Theor Med Bioeth       Date:  2003

4.  Induction of tolerance to cardiac allografts using donor splenocytes engineered to display on their surface an exogenous fas ligand protein.

Authors:  Esma S Yolcu; Xiao Gu; Chantale Lacelle; Hong Zhao; Laura Bandura-Morgan; Nadir Askenasy; Haval Shirwan
Journal:  J Immunol       Date:  2008-07-15       Impact factor: 5.422

Review 5.  Gene therapy in the treatment of intestinal inflammation.

Authors:  Catherine van Montfrans; Anje A te Velde; Sander J H van Deventer; Maria Sol Rodriguez Pena
Journal:  Int J Colorectal Dis       Date:  2003-06-25       Impact factor: 2.571

6.  Tumor cells engineered to codisplay on their surface 4-1BBL and LIGHT costimulatory proteins as a novel vaccine approach for cancer immunotherapy.

Authors:  R K Sharma; E S Yolcu; K G Elpek; H Shirwan
Journal:  Cancer Gene Ther       Date:  2010-06-18       Impact factor: 5.987

7.  Scavenger receptors and their potential as therapeutic targets in the treatment of cardiovascular disease.

Authors:  Sam L Stephen; Katie Freestone; Sarah Dunn; Michael W Twigg; Shervanthi Homer-Vanniasinkam; John H Walker; Stephen B Wheatcroft; Sreenivasan Ponnambalam
Journal:  Int J Hypertens       Date:  2010-08-17       Impact factor: 2.420

8.  Towards a clinically relevant lentiviral transduction protocol for primary human CD34 hematopoietic stem/progenitor cells.

Authors:  Michelle Millington; Allison Arndt; Maureen Boyd; Tanya Applegate; Sylvie Shen
Journal:  PLoS One       Date:  2009-07-30       Impact factor: 3.240

9.  BioShuttle-mediated plasmid transfer.

Authors:  Klaus Braun; Leonie von Brasch; Ruediger Pipkorn; Volker Ehemann; Juergen Jenne; Herbert Spring; Juergen Debus; Bernd Didinger; Werner Rittgen; Waldemar Waldeck
Journal:  Int J Med Sci       Date:  2007-10-30       Impact factor: 3.738

10.  Gene therapy for Wiskott-Aldrich Syndrome-Long-term reconstitution and clinical benefits, but increased risk for leukemogenesis.

Authors:  Christian Joerg Braun; Maximilian Witzel; Anna Paruzynski; Kaan Boztug; Christof von Kalle; Manfred Schmidt; Christoph Klein
Journal:  Rare Dis       Date:  2014-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.